Radiotherapy for sinonasal malignancies: evidence, technology and resource-constrained settings

Sinonasal malignancies are rare, biologically heterogeneous tumours arising in a confined anatomical space bounded by the orbit, skull base and brain. This combination of rarity, histological heterogeneity and anatomical constraint influences treatment selection and limits the evidence available to guide it. Radiotherapy is central to management in both the postoperative and definitive settings, and intensity-modulated radiotherapy is now the photon standard, with proton and carbon-ion therapy available in a small number of centres. This review appraises the evidence underlying current practice. Pooled outcome data derived from mixed-histology institutional series are difficult to interpret; definitive radiotherapy cohorts are subject to confounding by treatment allocation; the clinical evidence supporting particle therapy is weaker than the dosimetric evidence; and the evidence base for elective nodal irradiation is inadequate. The review identifies where the evidence supports firm recommendations and where it does not. Because most patients with these tumours are treated in settings without particle therapy, routine magnetic resonance imaging (MRI) or daily volumetric image guidance, it also describes resource-adapted alternatives and their limitations.

Authors

Institutions

Publication Details

Journal
Academia oncology.
Published
2026-11-13
DOI
https://doi.org/10.20935/acadonco8606
Primary Topic
Head and Neck Surgical Oncology
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Radiotherapy for sinonasal malignancies: evidence, technology and resource-constrained settings

Shwetabh Sinha, Samarpita Mohanty, Sarbani Ghosh Laskar, Anuj Kumar
1 links
Academia oncology.
Head and Neck Surgical Oncology
article

Radiotherapy for sinonasal malignancies: evidence, technology and resource-constrained settings

Shwetabh Sinha, Samarpita Mohanty, Sarbani Ghosh Laskar, Anuj Kumar
article en

Abstract

Sinonasal malignancies are rare, biologically heterogeneous tumours arising in a confined anatomical space bounded by the orbit, skull base and brain. This combination of rarity, histological heterogeneity and anatomical constraint influences treatment selection and limits the evidence available to guide it. Radiotherapy is central to management in both the postoperative and definitive settings, and intensity-modulated radiotherapy is now the photon standard, with proton and carbon-ion therapy available in a small number of centres. This review appraises the evidence underlying current practice. Pooled outcome data derived from mixed-histology institutional series are difficult to interpret; definitive radiotherapy cohorts are subject to confounding by treatment allocation; the clinical evidence supporting particle therapy is weaker than the dosimetric evidence; and the evidence base for elective nodal irradiation is inadequate. The review identifies where the evidence supports firm recommendations and where it does not. Because most patients with these tumours are treated in settings without particle therapy, routine magnetic resonance imaging (MRI) or daily volumetric image guidance, it also describes resource-adapted alternatives and their limitations.

Academia oncology.Vol. 3(4)
Homi Bhabha National Institute (IN), Tata Memorial Hospital (IN)
Tata Memorial Centre
Good health and well-being
Head and Neck Surgical Oncology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon